UBS Group’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.67M Buy
744,142
+326,177
+78% +$2.6M ﹤0.01% 3768
2025
Q4
$2.52M Buy
417,965
+203,203
+95% +$1.21M ﹤0.01% 4744
2025
Q3
$1.23M Sell
214,762
-100,405
-32% -$513K ﹤0.01% 5389
2025
Q2
$1.59M Sell
315,167
-162,229
-34% -$870K ﹤0.01% 5038
2025
Q1
$3.09M Buy
477,396
+237,283
+99% +$2.11M ﹤0.01% 4284
2024
Q4
$1.76M Sell
240,113
-143,075
-37% -$1.13M ﹤0.01% 4839
2024
Q3
$2.87M Buy
383,188
+89,713
+31% +$779K ﹤0.01% 3644
2024
Q2
$2.61M Sell
293,475
-172,733
-37% -$1.66M ﹤0.01% 3486
2024
Q1
$4.72M Sell
466,208
-59,972
-11% -$611K ﹤0.01% 3039
2023
Q4
$5.29M Buy
526,180
+240,648
+84% +$2.2M ﹤0.01% 2731
2023
Q3
$2.68M Buy
285,532
+74,704
+35% +$1.07M ﹤0.01% 3165
2023
Q2
$5.17M Buy
210,828
+88,702
+73% +$2.23M ﹤0.01% 2555
2023
Q1
$2.84M Sell
122,126
-167,601
-58% -$4.29M ﹤0.01% 3050
2022
Q4
$7.33M Buy
289,727
+185,199
+177% +$4.54M ﹤0.01% 2147
2022
Q3
$2.02M Sell
104,528
-22,347
-18% -$568K ﹤0.01% 3156
2022
Q2
$3.23M Sell
126,875
-194,178
-60% -$4.53M ﹤0.01% 2733
2022
Q1
$8.26M Buy
321,053
+225,346
+235% +$6.68M ﹤0.01% 2086
2021
Q4
$4.01M Buy
95,707
+75,375
+371% +$2.95M ﹤0.01% 3068
2021
Q3
$884K Sell
20,332
-1,459
-7% -$63.2K ﹤0.01% 4293
2021
Q2
$1.03M Sell
21,791
-13,185
-38% -$599K ﹤0.01% 4147
2021
Q1
$1.79M Sell
34,976
-10,515
-23% -$567K ﹤0.01% 3667
2020
Q4
$1.22M Sell
45,491
-19,930
-30% -$648K ﹤0.01% 3858
2020
Q3
$2.25M Buy
65,421
+27,993
+75% +$1.21M ﹤0.01% 2940
2020
Q2
$1.53M Buy
37,428
+33,241
+794% +$1.12M ﹤0.01% 3133
2020
Q1
$143K Sell
4,187
-7,770
-65% -$209K ﹤0.01% 4984
2019
Q4
$150K Buy
+11,957
New +$160K ﹤0.01% 5782

Other funds holding VIR